Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2010
Update on research and development pipeline: tuberculosis vaccinesBelinda Beresford, Jerald C Sadoff
Microbes and Infection|May 10, 2005
The role of "go no-go" decisions in TB vaccine developmentJerald C Sadoff, David Hone
Nature Reviews. Microbiology|May 20, 2006
Advances in tuberculosis vaccine strategiesYasir A W Skeiky, Jerald C Sadoff
BMC Medical Genomics|May 29, 2008
Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analysesAnat Zvi, Naomi Ariel, John Fulkerson, et al.
Current Opinion in Immunology|June 10, 2009
Tuberculosis vaccine research: the impact of immunologyLewellys F Barker, Michael J Brennan, Peri K Rosenstein, et al.
European Journal of Immunology|September 21, 2011
Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectorsRichard Hopkins, Anne Bridgeman, Charles Bourne, et al.
Journal of Virology|May 21, 2010
Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaquesMaximillian Rosario, John Fulkerson, Shamit Soneji, et al.
The Journal of Infectious Diseases|September 24, 2008
A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteersDaniel F Hoft, Azra Blazevic, Getahun Abate, et al.
The Pediatric Infectious Disease Journal|June 22, 2002
Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infectionShu Li, Ivan S F Chan, Holly Matthews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2003
Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 childrenTerhi Kilpi, Heidi Ahman, Jukka Jokinen, et al.
Pageof 3